Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (281-290 of 484) with videos related to

Pageof 49
Sort By:
Cancer Research|July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude miceJ W Pearson, D J FitzGerald, M C Willingham, et al.
Seminars in Oncology|December 1, 1992
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapyW J Urba, W H Wilson, P L Duffey, et al.
Seminars in Hematology|April 1, 1988
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatmentR C Young, D L Longo, E Glatstein, et al.
Experimental Hematology|June 1, 1993
Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factorK Hestdal, S E Jacobsen, F W Ruscetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 1991
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomasR I Fisher, D L Longo, V T DeVita, et al.
Cancer Research|November 15, 1995
In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenograftsZ G Tian, D L Longo, S Funakoshi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
Autoreactive B cells escape clonal deletion by expressing multiple antigen receptorsJ J Kenny, L J Rezanka, A Lustig, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1991
p34cdc2 is physically associated with and phosphorylated by a cdc2-specific tyrosine kinaseD K Ferris, G A White, D J Kelvin, et al.
Blood|July 1, 1994
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptorK Hestdal, F W Ruscetti, R Chizzonite, et al.
Biochemical and Biophysical Research Communications|May 19, 1997
Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinaseM R Smith, M L Wilson, R Hamanaka, et al.
Pageof 49

Showing results (281-290 of 484) with videos related to

Sort By:
Pageof 49
Cancer Research|July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude miceJ W Pearson, D J FitzGerald, M C Willingham, et al.
Seminars in Oncology|December 1, 1992
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapyW J Urba, W H Wilson, P L Duffey, et al.
Seminars in Hematology|April 1, 1988
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatmentR C Young, D L Longo, E Glatstein, et al.
Experimental Hematology|June 1, 1993
Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factorK Hestdal, S E Jacobsen, F W Ruscetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 1991
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomasR I Fisher, D L Longo, V T DeVita, et al.
Cancer Research|November 15, 1995
In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenograftsZ G Tian, D L Longo, S Funakoshi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
Autoreactive B cells escape clonal deletion by expressing multiple antigen receptorsJ J Kenny, L J Rezanka, A Lustig, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1991
p34cdc2 is physically associated with and phosphorylated by a cdc2-specific tyrosine kinaseD K Ferris, G A White, D J Kelvin, et al.
Blood|July 1, 1994
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptorK Hestdal, F W Ruscetti, R Chizzonite, et al.
Biochemical and Biophysical Research Communications|May 19, 1997
Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinaseM R Smith, M L Wilson, R Hamanaka, et al.
Pageof 49